Css LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $242,064 - $317,112	2,400 New	2,400 $310,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $4.44 Million - $6.33 Million	35,400 Added 175.25%	55,600 $9.48 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $2.06 Million - $2.79 Million	16,200 Added 405.0%	20,200 $2.84 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $297,600 - $549,440	-3,200 Reduced 44.44%	4,000 $641,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $229,590 - $406,740	-3,000 Reduced 29.41%	7,200 $929,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $495,108 - $1.07 Million	-6,800 Reduced 40.0%	10,200 $768,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $809,880 - $964,750	17,000	17,000 $946,000

530

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.